Using a functional protein pathway activation mapping approach coupled with genomic analysis approach, the present studies are the first to identify ALK signaling as a potential driver in pre-clinical models of IBC that recapitulate the formation of tumor emboli when grown as xenografts which we demonstrate have either ALK signaling activation, low level gene amplification, and/or ALK gene expression. The gene discussed is ALK; the disease is neoplasm.